DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr | ₹7.06 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.00 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹89 Cr |
| Mar2021 | ₹7.06 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.00 Cr | -96.89 | |
| Mar2024 | ₹257 Cr | 188.76 | |
| Mar2023 | ₹89 Cr | -0.03 | |
| Mar2022 | ₹89 Cr | 1,161.05 | |
| Mar2021 | ₹7.06 Cr | - | |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,667.8 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
| MANKIND PHARMA | ₹99,323.5 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.1% |
-2.5% |
-0.1% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses